We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWN:NYSENorthwest Natural Holding Company Analysis

Data as of 2026-04-21 - not real-time

$52.58

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock trades just above a key support level around $51, with the 20‑day SMA sitting above the 50‑day and 200‑day averages, suggesting a short‑term bullish bias despite a bearish MACD histogram and decreasing volume that temper enthusiasm. RSI is in the low‑40s, indicating neither overbought nor oversold conditions, while the Fear & Greed Index shows “Extreme Greed,” reflecting strong market appetite for risk. Technical signals are mixed, but the price remains constrained by a clear resistance near $56.
Fundamentally, NWN offers a generous dividend yield of roughly 3.7% with a payout ratio near 71%, yet free cash flow is negative and debt‑to‑equity exceeds 180%, raising questions about dividend sustainability. The DCF fair‑value estimate sits well below the current price, implying limited upside of about 8% and a valuation that appears stretched. Recent material news includes an earnings call that reaffirmed guidance, a modest insider sale by a senior VP, and a downgrade from buy to hold, all of which add caution to the outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram and decreasing volume
  • Recent downgrade from buy to hold
  • Price testing a near‑term support level

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Stable regulated revenue base with modest growth
  • Attractive dividend yield for income investors
  • High debt load and negative free cash flow limiting financial flexibility

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Defensive utility sector with low beta
  • Long‑term demand for natural gas distribution
  • Consistent dividend payout despite current valuation stretch

Key Metrics & Analysis

Financial Health

Revenue Growth6.30%
Profit Margin8.79%
P/E Ratio19.0
ROE7.92%
ROA2.95%
Debt/Equity181.89
P/B Ratio1.5
Op. Cash Flow$269.1M
Free Cash Flow$-162616880
Industry P/E22.1

Technical Analysis

TrendBullish
RSI42.7
Support$51.01
Resistance$55.99
MA 20$53.99
MA 50$52.26
MA 200$46.51
MACDBearish
VolumeDecreasing
Fear & Greed Index86.63

Valuation

Fair Value$16.97
Target Price$56.75
Upside/Downside7.93%
GradeOvervalued
TypeValue
Dividend Yield3.69%

Risk Assessment

Beta-0.01
Volatility17.49%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.